Westchester Capital Management (New York)’s Aimei Health Technology Co Unit AFJKU Stock Holding History

Westchester Capital Management (New York)’s Portfolio AFJKU Stock Details AFJKU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-288,212	Closed	-$2.94M	–	314
2023 Q4	$2.94M	Buy	+288,212	New	+$2.93M	0.1%	129

Other funds holding AFJKU

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Walleye Trading New York $87.6B AUM 68.17% 1-Year Est. Return

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Westchester Capital Management (New York)'s AFJKU Position: Q1 2024 in Review

Westchester Capital Management (New York) sold out of Aimei Health Technology Co Unit (AFJKU) in Q1 2024, closing a stake of 288,212 shares — an estimated $2.94M sold.

Westchester Capital Management (New York) first reported a position in AFJKU in Q4 2023 and held it in 1 quarter. The position peaked at $2.94M in Q4 2023. 6 funds tracked by Wall St. Rank hold AFJKU as of Q1 2024.

Westchester Capital Management (New York) reported no remaining Aimei Health Technology Co Unit position as of Q1 2024 after selling out during the quarter.
Westchester Capital Management (New York) sold 288,212 Aimei Health Technology Co Unit shares in Q1 2024, an estimated $2.94M.
Westchester Capital Management (New York) first reported a position in Aimei Health Technology Co Unit in Q4 2023 and held it in 1 quarter.
Westchester Capital Management (New York)'s Aimei Health Technology Co Unit position peaked at $2.94M in Q4 2023.
6 funds tracked by Wall St. Rank held Aimei Health Technology Co Unit as of Q1 2024.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2024, filed 15 May 2024.